Anthony S. Fiorino insider trades: Immune Pharmaceuticals (IMNPQ) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Anthony reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 3, 2020 | IMNPQ | ↓ Sell | 75,000 | $0.00 | $263 | Direct | Feb 4, 2020 (1d) |
| May 22, 2018 | IMNP | ↑ Buy | 25,000 | $0.24 | $6K | Direct | May 23, 2018 (1d) |
| May 17, 2018 | IMNP | ↑ Buy | 50,000 | $0.26 | $13K | Direct | May 18, 2018 (1d) |
| Oct 15, 2014 | BCLI | ↑ Buy | 500 | $3.60 | $2K | Direct | Oct 15, 2014 (0d) |
| Sep 18, 2014 | BCLI | ↑ Buy | 800 | $3.84 | $3K | Direct | Sep 19, 2014 (1d) |
| Sep 15, 2014 | BCLI | ↑ Buy | 18,000 | $0.28 | $5K | Direct | Sep 16, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Anthony S. Fiorino's insider trades
Anthony S. Fiorino is a director at Immune Pharmaceuticals (IMNPQ). Since Sep 15, 2014, Anthony has reported 5 open-market purchases worth $29K and 1 sale worth $263 on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMNPQ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.